N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer-Reference-Cited by-同舟云学术

N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer

Published:2021-06 Issue:13 Volume:433 Page:167003
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Arutyunova Elena,Khan Muhammad Bashir,Fischer Conrad^ORCID,Lu Jimmy,Lamer Tess^ORCID,Vuong Wayne^ORCID,van Belkum Marco J.,McKay Ryan T.^ORCID,Tyrrell D. Lorne,Vederas John C.,Young Howard S.,Lemieux M. Joanne

Funder

NSERC

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference51 articles.

1. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

2. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

3. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China;Wu;Cell Host Microbe,2020

4. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status;Abd El-Aziz;Infect. Genet. Evol.,2020

5. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2;Gorbalenya;Nat. Microbiol.,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. β-Tocotrienol and δ-Tocotrienol as Additional Inhibitors of the Main Protease of Feline Infectious Peritonitis Virus: An In Silico Analysis;Veterinary Sciences;2024-09-11

3. Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (M^pro);ACS Omega;2024-08-02

4. 3-chymotrypsin-like protease in SARS-CoV-2;Bioscience Reports;2024-08

5. A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (M^pro) of SARS-CoV-2 and MERS-CoV;JACS Au;2024-07-30